§ 13F · FUND PROFILE
BIOS Capital Management, LP.
AUM · $42M (13F)Positions · 9Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | IRD | OPUS GENETICS INC | 3.68M | $15M | 36.3% | ±0% |
| 2 | ACTU | ACTUATE THERAPEUTICS INC | 8.59M | $13M | 31.6% | ±0% |
| 3 | CGTX | COGNITION THERAPEUTICS INC | 5.50M | $6M | 15.2% | ±0% |
| 4 | ACTU | ACTUATE THERAPEUTICS INC | 1.46M | $2M | 5.3% | — |
| 5 | RNTX | REIN THERAPEUTICS INC | 1.76M | $2M | 4.4% | +50% |
| 6 | RNTX | REIN THERAPEUTICS INC | 1.22M | $1M | 3.1% | — |
| 7 | LTRN | LANTERN PHARMA INC | 249K | $1M | 2.5% | −71% |
| 8 | CGTX | COGNITION THERAPEUTICS INC | 500K | $575K | 1.4% | — |
| 9 | INAB | IN8BIO INC | 81K | $114K | 0.3% | −52% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE BIOS SIGNAL
AC read
BIOS Capital Management, LP is a Other fund managing $42 million in assets. The fund runs a focused portfolio of just 9 positions.
Read the full dossier →